PTX 0.00% 4.0¢ prescient therapeutics limited

Ann: Interim Durability Analysis of PTX-200 Breast Cancer Study, page-21

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,007 Posts.
    lightbulb Created with Sketch. 105
    All the results were positive, breast cancer survival after 27 months, all cancer gooone,
    & all recipients in trial are all alive & well, cured. WOW.

    A breast cancer sufferer is usually dead within 27 months according to statistics.

    Massive break through, PTX 200 is also in trial for ovarian cancer.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.000(0.00%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.1¢ 4.0¢ $22.35K 558.4K

Buyers (Bids)

No. Vol. Price($)
6 221774 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 860576 3
View Market Depth
Last trade - 14.51pm 19/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.